These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34391891)

  • 1. Discovery of IDO1 inhibitors containing a decahydroquinoline, decahydro-1,6-naphthyridine, or octahydro-1H-pyrrolo[3,2-c]pyridine scaffold.
    Yu W; Deng Y; Sloman D; Li D; Liu K; Fradera X; Lesburg CA; Martinot T; Doty A; Ferguson H; Richard Miller J; Knemeyer I; Otte K; Vincent S; Sciammetta N; Jonathan Bennett D; Han Y
    Bioorg Med Chem Lett; 2021 Oct; 49():128314. PubMed ID: 34391891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions.
    Tomek P; Palmer BD; Flanagan JU; Sun C; Raven EL; Ching LM
    Eur J Med Chem; 2017 Jan; 126():983-996. PubMed ID: 28011425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of 5-(N-hydroxycarbamimidoyl) benzofuran derivatives as novel indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
    Jung J; Yoon H; Sohn TI; Jang K; Yoo Y; Jeong I; Shin JE; Lee JH; Ann J; Lee J
    Bioorg Med Chem Lett; 2021 May; 40():127963. PubMed ID: 33741464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of 5-(pyridin-3-yl)-1H-indole-4,7-diones as indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
    Kong KM; Zhang JW; Liu BZ; Meng GR; Zhang Q
    Bioorg Med Chem Lett; 2020 Feb; 30(4):126901. PubMed ID: 31882299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SAR towards indoline and 3-azaindoline classes of IDO1 inhibitors.
    Yu W; Deng Y; Hopkins B; Huang X; Sloman D; Zhang H; Li D; McGowan MA; White C; Pu Q; Liu K; Fradera X; Lesburg CA; Martinot T; Doty A; Ferguson H; Nickbarg EB; Cheng M; Geda P; Song X; Smotrov N; Abeywickrema P; Andrews C; Chamberlin C; Mabrouk O; Curran P; Richards M; Saradjian P; Miller JR; Knemeyer I; Otte K; Vincent S; Sciammetta N; Bennett DJ; Han Y
    Bioorg Med Chem Lett; 2021 Sep; 47():128214. PubMed ID: 34166782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indoleamine 2,3-dioxygenase inhibitory activity of derivatives of marine alkaloid tsitsikammamine A.
    Dolušić E; Larrieu P; Meinguet C; Colette D; Rives A; Blanc S; Ferain T; Pilotte L; Stroobant V; Wouters J; Van den Eynde B; Masereel B; Delfourne E; Frédérick R
    Bioorg Med Chem Lett; 2013 Jan; 23(1):47-54. PubMed ID: 23218716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and preliminary structure-activity relationships of 1-Indanone derivatives as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors.
    Gao D; Li Y
    Bioorg Med Chem; 2017 Jul; 25(14):3780-3791. PubMed ID: 28526475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational design, synthesis and biological evaluation of ubiquinone derivatives as IDO1 inhibitors.
    Ding Y; Tang F; Xue X; Luo J; Hussain M; Huang Y; Wang Z; Jiang H; Tu Z; Zhang J
    Bioorg Chem; 2019 Aug; 89():102870. PubMed ID: 31103493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of cyanopyridine scaffold as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors through virtual screening and preliminary hit optimisation.
    Xu X; Ren J; Ma Y; Liu H; Rong Q; Feng Y; Wang Y; Cheng Y; Ge R; Li Z; Bian J
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):250-263. PubMed ID: 30734612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, Docking and Biological Evaluation of a Novel Class of Imidazothiazoles as IDO1 Inhibitors.
    Serafini M; Torre E; Aprile S; Massarotti A; Fallarini S; Pirali T
    Molecules; 2019 May; 24(10):. PubMed ID: 31096672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a Novel Scaffold as an Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Based on the Pyrrolopiperazinone Alkaloid, Longamide B.
    Shiokawa Z; Kashiwabara E; Yoshidome D; Fukase K; Inuki S; Fujimoto Y
    ChemMedChem; 2016 Dec; 11(24):2682-2689. PubMed ID: 27863031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Series of 2-((1-Phenyl-1H-imidazol-5-yl)methyl)-1H-indoles as Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
    Zheng Y; Stafford PM; Stover KR; Mohan DC; Gupta M; Keske EC; Schiavini P; Villar L; Wu F; Kreft A; Thomas K; Raaphorst E; Pasangulapati JP; Alla SR; Sharma S; Mittapalli RR; Sagamanova I; Johnson SL; Reed MA; Weaver DF
    ChemMedChem; 2021 Jul; 16(14):2195-2205. PubMed ID: 33759400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Molecular Modeling Studies of N'-Hydroxyindazolecarboximidamides as Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
    Lee DH; Lee JY; Jeong J; Kim M; Lee KW; Jang E; Ahn S; Lee CH; Hwang JY
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29120388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel IDO1 inhibitors via structure-based virtual screening and biological assays.
    Ge H; Mao L; Zhao J; Wang Y; Shi D; Yang X; Wang X; Liu H; Yao X
    J Comput Aided Mol Des; 2021 May; 35(5):679-694. PubMed ID: 33905074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, Synthesis and Biological Evaluation of Phenyl Urea Derivatives as IDO1 Inhibitors.
    Zhou C; Lai F; Sheng L; Chen X; Li Y; Feng Z
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32210078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a series of novel o-phenylenediamine-based indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
    Williams DK; Markwalder JA; Balog AJ; Chen B; Chen L; Donnell J; Haque L; Hart AC; Mandal SK; Nation A; Shan W; Vite GD; Covello K; Hunt JT; Jure-Kunkel MN; Seitz SP
    Bioorg Med Chem Lett; 2018 Feb; 28(4):732-736. PubMed ID: 29398543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and comparison of the commonly used bioassays of human indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO).
    Zhang S; Guo L; Yang D; Xing Z; Li W; Kuang C; Yang Q
    Bioorg Chem; 2020 Nov; 104():104348. PubMed ID: 33142415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of 7H-pyrrolo[2,3-d]pyrimidine derivatives containing 1,8-naphthyridine-4-one fragment.
    Zhang J; Chen P; Duan Y; Xiong H; Li H; Zeng Y; Liang G; Tang Q; Wu D
    Eur J Med Chem; 2021 Apr; 215():113273. PubMed ID: 33601310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent discovery of indoleamine-2,3-dioxygenase 1 inhibitors targeting cancer immunotherapy.
    Weng T; Qiu X; Wang J; Li Z; Bian J
    Eur J Med Chem; 2018 Jan; 143():656-669. PubMed ID: 29220788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and structure-activity relationship study of novel naphthoindolizine and indolizinoquinoline-5,12-dione derivatives as IDO1 inhibitors.
    Yang R; Chen Y; Pan L; Yang Y; Zheng Q; Hu Y; Wang Y; Zhang L; Sun Y; Li Z; Meng X
    Bioorg Med Chem; 2018 Sep; 26(17):4886-4897. PubMed ID: 30170925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.